Recent antiepileptic and neuroprotective applications of brain cooling

Seizure. 2020 Nov:82:80-90. doi: 10.1016/j.seizure.2020.09.018. Epub 2020 Sep 28.

Abstract

Hypothermia is a widely used clinical practice for neuroprotection and is a well-established method to mitigate the adverse effects of some clinical conditions such as reperfusion injury after cardiac arrest and hypoxic ischemic encephalopathy in newborns. The discovery, that lowering the core temperature has a therapeutic potential dates back to the early 20th century, but the underlying mechanisms are actively researched, even today. Especially, in the area of neural disorders such as epilepsy and traumatic brain injury, cooling has promising prospects. It is well documented in animal models, that the application of focal brain cooling can effectively terminate epileptic discharges. There is, however, limited data regarding human clinical trials. In this review article, we will discuss the main aspects of therapeutic hypothermia focusing on its use in treating epilepsy. The various experimental approaches and device concepts for focal brain cooling are presented and their potential for controlling and suppressing seizure activity are compared.

Keywords: Brain cooling; Epilepsy; Hypothermia; Neuroprotection; Peltier-device; Seizures.

Publication types

  • Review

MeSH terms

  • Animals
  • Anticonvulsants
  • Brain* / physiology
  • Epilepsy* / therapy
  • Humans
  • Hypothermia, Induced*
  • Hypoxia-Ischemia, Brain* / therapy
  • Infant, Newborn
  • Neuroprotection

Substances

  • Anticonvulsants